Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiske stoffer til suidae - svin (slagtekyllinger) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

navamedic asa - clindamycinphosphat - infusionsvæske, opløsning - 300 mg

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

alk-abello a/s - hesteskæl - opløsning til priktest (soluprick-sq) - 10 hep

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - cefuroximnatrium - pulver og solvens til infusionsvæske, opløsning - 750 mg

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

merial norden a/s - mycoplasma hyopneumonia, stamme bq 14 (inaktiveret) - injektionsvæske, suspension - svin

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

laboratorios hipra s.a. - mycoplasma hyopneumonia, stamme j (inaktiveret) - injektionsvæske, suspension - 50 amu - svin

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

navamedic asa - cefuroxim - pulver til injektions-/infusionsvæske, opløsning - 250 mg

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - levofloxacinhemihydrat - infusionsvæske, opløsning - 5 mg/ml

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

mip pharma gmbh - cefotaximnatrium - pulver til injektions-/infusionsvæske, opløsning - 2 g

Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

infectopharm gmbh - fosfomycinnatrium - pulver til infusionsvæske, opløsning - 40 mg/ml